HPV Vaccination Adherence in Working-Age Men: A Systematic Review and Meta-Analysis
Authors:
- Carlotta AmanteaCACarlotta Amantea
- Nazario FoschiNazario Foschi
- Filippo GaviFilippo Gavi
- Ivan BorrelliIBIvan Borrelli
- Maria Francesca RossiMRMaria Francesca Rossi
- Valerio SpuntarelliVSValerio Spuntarelli
- Pierluigi RussoPRPierluigi Russo
- Maria Rosaria GualanoMGMaria Rosaria Gualano
- Paolo Emilio SantoroPaolo Emilio Santoro
- Umberto MoscatoUMUmberto Moscato
Open Access
Abstract
Background: Human papillomavirus (HPV) infection is the most common sexually transmitted viral infection in the world. HPV vaccination adherence rates in men are generally lower than in women. The aim of this systematic review and meta-analysis was to assess adherence to HPV vaccination in young working-age males (18–30 years old). Methods: A systematic review was performed using three databases: PubMed, Scopus, and Web of Science, according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Results: After duplicate removal, the initial search resulted in 478 eligible papers. With the exclusion of 425 papers after screening the abstracts, full texts of 53 articles were reviewed. Subsequently, 45 were excluded. Among the eight studies included, four (50%) examined the vaccination adherence in young adults through data registered in nationwide insurance or private companies’ databases, three (37.5%) in young adults in different settings through data collected from surveys and questionnaires, and one (12.5%) an HPV vaccination campaign in a family medicine residency practice. Conclusion: Adherence to HPV vaccination in men of working age (18–30 years) does not appear to be adequate (pooled prevalence 11%). In order to achieve a higher level of compliance, it is important to place an emphasis on vaccination campaigns in schools as well as in the workplace, after consultation with and approval from local, regional, and federal public health agencies.Keywords
This publication has 77 references indexed in Scilit:
- Potential impact of a nine-valent vaccine in human papillomavirus related cervical diseaseInfectious Agents and Cancer, 2012
- Addressing Health Inequalities in the Delivery of the Human Papillomavirus Vaccination Programme: Examining the Role of the School NursePLOS ONE, 2012
- Perspective: Vaccinate boys tooNature, 2012
- School nurses' experiences of delivering the UK HPV vaccination programme in its first yearBMC Infectious Diseases, 2011
- Serum Antibody Response Following Genital 9 Human Papillomavirus Infection in Young MenThe Journal of Infectious Diseases, 2011
- Challenges and opportunities of a new HPV immunization programVaccine, 2011
- Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort studyThe Lancet, 2011
- Epidemiology and pathology of HPV disease in malesGynecologic Oncology, 2010
- The Human Papillomavirus Infection in Men Study: Human Papillomavirus Prevalence and Type Distribution among Men Residing in Brazil, Mexico, and the United StatesCancer Epidemiology, Biomarkers & Prevention, 2008
- Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countriesVaccine, 2008